Product Information

GUANFACINE HCL ER 2 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1573 per EA under NDC 70436004001. Its NADAC has been published 198 times since Nov 9, 2022.

FDA first approved this application on Nov 25, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GUANFACINE HCL ER 2 MG TABLET

guanfacine
$0.1573per EA

Strength

2 mg/1

NDC

70436004001

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GUANFACINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213428

FDA Approved

11/25/2020

TE Code

AB

On Market Since

8/1/2022

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for GUANFACINE HCL ER 2 MG TABLET has been published 198 times since Nov 9, 2022, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1573 per EA
All-time high$0.2622 (Dec 14, 2022)
All-time low$0.1573 (Aug 19, 2026)
52-week high$0.2166
52-week low$0.1573
Median price$0.2072
Average price$0.2072
Largest weekly change+25.8% (Jun 19, 2024)
Weeks tracked198
Tracking sinceNov 9, 2022

Price History

1W

-5.2%

1M

-5.2%

3M

-12.9%

6M

-23.5%

1Y

-21.4%

3Y

-26.6%

5Y

N/A

All

-39.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GUANFACINE HCL ER 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GUANFACINE HCL ER 2 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.1573 per EA (NDC 70436004001), effective Aug 19, 2026.

How has the price of GUANFACINE HCL ER 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for GUANFACINE HCL ER 2 MG TABLET has declined 39.7%. It has been tracked across 198 weekly CMS publications since Nov 9, 2022.

What are the highest and lowest recorded NADAC prices for GUANFACINE HCL ER 2 MG TABLET?

Since Nov 9, 2022, the NADAC for GUANFACINE HCL ER 2 MG TABLET has ranged from a low of $0.1573 (Aug 19, 2026) to a high of $0.2622 (Dec 14, 2022), with a median of $0.2072 per EA.

Are there cheaper alternatives to GUANFACINE HCL ER 2 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GUANFACINE HCL ER 2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GUANFACINE HCL ER 2 MG TABLET?

GUANFACINE HCL ER 2 MG TABLET (NDC 70436004001) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.